Now Is The Time To Build A Position In Unicycive Therapeutics Inc (NASDAQ:UNCY)
In the last trading session, 1.79 million Unicycive Therapeutics Inc (NASDAQ:UNCY) shares changed hands as the company’s beta touched 1.98. With the company’s per share
In the last trading session, 1.79 million Unicycive Therapeutics Inc (NASDAQ:UNCY) shares changed hands as the company’s beta touched 1.98. With the company’s per share
Unicycive Therapeutics Inc (NASDAQ:UNCY) has a beta value of 2.00 and has seen 1.83 million shares traded in the last trading session. The company, currently
During the last session, Unicycive Therapeutics Inc (NASDAQ:UNCY)’s traded shares were 7.55 million, with the beta value of the company hitting 2.01. At the end
In the last trading session, 49.41 million Unicycive Therapeutics Inc (NASDAQ:UNCY) shares changed hands as the company’s beta touched 2.04. With the company’s per share
In last trading session, Unicycive Therapeutics Inc (NASDAQ:UNCY) saw 3.53 million shares changing hands with its beta currently measuring 2.01. Company’s recent per share price
Unicycive Therapeutics Inc (NASDAQ:UNCY) has a beta value of 2.00 and has seen 2.87 million shares traded in the last trading session. The company, currently
In the last trading session, 0.47 million shares of the Unicycive Therapeutics Inc (NASDAQ:UNCY) were traded, and its beta was 2.02. Most recently the company’s
© 2024, Powered by Smart TechOne